Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Mallinckrodt
Federal Trade Commission
Cerilliant
Johnson and Johnson
Farmers Insurance
Deloitte
McKesson
Fish and Richardson

Generated: October 23, 2017

DrugPatentWatch Database Preview

COREG Drug Profile

« Back to Dashboard

Which patents cover Coreg, and what generic Coreg alternatives are available?

Coreg is a drug marketed by Smithkline Beecham and is included in two NDAs. There are two patents protecting this drug and three Paragraph IV challenges.

The generic ingredient in COREG is carvedilol phosphate. There are thirty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the carvedilol phosphate profile page.

Summary for Tradename: COREG

US Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list3
Bulk Api Vendors: see list81
Clinical Trials: see list32
Patent Applications: see list4,818
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:COREG at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-004May 29, 1997ABRXYesNo► Subscribe► Subscribe► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-002Oct 20, 2006RXYesNo► Subscribe► SubscribeY► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-001Sep 14, 1995ABRXYesNo► Subscribe► Subscribe► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-004Oct 20, 2006RXYesNo► Subscribe► SubscribeY► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-002Oct 20, 2006RXYesNo► Subscribe► SubscribeY► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-003Sep 14, 1995ABRXYesNo► Subscribe► Subscribe► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-002Sep 14, 1995ABRXYesYes► Subscribe► Subscribe► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-001Oct 20, 2006RXYesNo► Subscribe► SubscribeY► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-001Oct 20, 2006RXYesNo► Subscribe► SubscribeY► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-003Oct 20, 2006RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: COREG

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-004May 29, 1997► Subscribe► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-002Sep 14, 1995► Subscribe► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-001Sep 14, 1995► Subscribe► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-001Sep 14, 1995► Subscribe► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-003Sep 14, 1995► Subscribe► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-001Sep 14, 1995► Subscribe► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-002Sep 14, 1995► Subscribe► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-003Sep 14, 1995► Subscribe► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-001Sep 14, 1995► Subscribe► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-002Sep 14, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for COREG

Drugname Dosage Strength RLD Submissiondate
carvedilol phosphateExtended-release Capsules10 mg and 20 mgCoreg CR3/18/2008
carvedilol phosphateExtended-release Capsules40 mgCoreg CR12/21/2007
carvedilol phosphateExtended-release Capsules80 mgCoreg CR11/19/2007
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Chinese Patent Office
Deloitte
Medtronic
Daiichi Sankyo
Farmers Insurance
Accenture
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot